These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15732870)

  • 41. A clinical and radiological evaluation of DFDBA with amniotic membrane versus bovine derived xenograft with amniotic membrane in human periodontal grade II furcation defects.
    Kothiwale SV; Anuroopa P; Gajiwala AL
    Cell Tissue Bank; 2009 Nov; 10(4):317-26. PubMed ID: 19277899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
    Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
    J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation of nanocrystalline hydroxyapatite paste in the treatment of human periodontal bony defects--a randomized controlled clinical trial: 6-month results.
    Kasaj A; Röhrig B; Zafiropoulos GG; Willershausen B
    J Periodontol; 2008 Mar; 79(3):394-400. PubMed ID: 18315420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periodontal repair in intrabony defects treated with a calcium sulfate implant and calcium sulfate barrier.
    Kim CK; Chai JK; Cho KS; Moon IS; Choi SH; Sottosanti JS; Wikesjo UM
    J Periodontol; 1998 Dec; 69(12):1317-24. PubMed ID: 9926761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
    Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
    J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.
    Yukna RA; Callan DP; Krauser JT; Evans GH; Aichelmann-Reidy ME; Moore K; Cruz R; Scott JB
    J Periodontol; 1998 Jun; 69(6):655-63. PubMed ID: 9660334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical evaluation of Bio-Oss: a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Richardson CR; Mellonig JT; Brunsvold MA; McDonnell HT; Cochran DL
    J Clin Periodontol; 1999 Jul; 26(7):421-8. PubMed ID: 10412845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A clinical evaluation of anorganic bovine bone graft plus 10% collagen with or without a barrier in the treatment of class II furcation defects.
    Reddy KP; Nayak DG; Uppoor AS
    J Contemp Dent Pract; 2006 Feb; 7(1):60-70. PubMed ID: 16491148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane.
    Orsini M; Orsini G; Benlloch D; Aranda JJ; Sanz M
    J Periodontol; 2008 Sep; 79(9):1630-7. PubMed ID: 18771362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.
    Yukna RA; Krauser JT; Callan DP; Evans GH; Cruz R; Martin M
    J Periodontol; 2002 Jan; 73(1):123-8. PubMed ID: 11846193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Healing of intrabony defects following treatment with a bovine-derived xenograft and collagen membrane. A controlled clinical study.
    Sculean A; Berakdar M; Chiantella GC; Donos N; Arweiler NB; Brecx M
    J Clin Periodontol; 2003 Jan; 30(1):73-80. PubMed ID: 12702114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of bioactive glass in the treatment of periodontal defects: a meta-analysis of randomized controlled clinical trials.
    Sohrabi K; Saraiya V; Laage TA; Harris M; Blieden M; Karimbux N
    J Periodontol; 2012 Apr; 83(4):453-64. PubMed ID: 21861641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
    Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
    J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An evaluation of bovine derived xenograft with and without a bioabsorbable collagen membrane in the treatment of mandibular Class II furcation defects.
    Taheri M; Molla R; Radvar M; Sohrabi K; Najafi MH
    Aust Dent J; 2009 Sep; 54(3):220-7. PubMed ID: 19709109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans.
    Camargo PM; Lekovic V; Weinlaender M; Vasilic N; Madzarevic M; Kenney EB
    J Periodontal Res; 2002 Aug; 37(4):300-6. PubMed ID: 12200975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of fibronectin and a bone xenograft on regenerative treatment: a feasibility study.
    Camargo PM; Wolinsky LE; Ducar JP; Lagos R; Pirih FQ; Jeffcoat M; Goodheart C
    Compend Contin Educ Dent; 2006 Oct; 27(10):560-8; quiz 569, 581. PubMed ID: 17120390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.
    Cortellini P; Tonetti MS
    J Periodontol; 2005 Mar; 76(3):341-50. PubMed ID: 15857066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans.
    Ouyang XY; Qiao J
    Chin Med J (Engl); 2006 Sep; 119(18):1511-21. PubMed ID: 16996004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of angular bone defects with a composite bone grafting material in combination with a collagen membrane.
    Zitzmann NU; Rateitschak-Plüss E; Marinello CP
    J Periodontol; 2003 May; 74(5):687-94. PubMed ID: 12816302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictability of clinical outcomes following regenerative therapy in intrabony defects.
    Aichelmann-Reidy ME; Reynolds MA
    J Periodontol; 2008 Mar; 79(3):387-93. PubMed ID: 18315419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.